Humana AB has resolved to repurchase own shares
Under the authorisation from the Annual General Meeting 2020, the Board of Humana AB has resolved to repurchase own shares.
The purpose of the repurchases is to adjust the capital structure and thereby contribute to increased shareholder value. The company’s holding of own shares may ultimately be used as payment for or to finance acquisitions of companies and/or assets. The group’s financial position is considered to be strong, even after the resolved repurchases of shares, and provides the possibility to continue to develop the business.
Any repurchase will be made on Nasdaq Stockholm in accordance with the Nordic Main Market Rulebook for Issuers of Shares and will take place before the Annual General Meeting 2021. Own shares may be repurchased to the extent the company’s holdings of own shares in total amounts to no more than 10 per cent of the total number of shares in the company.
The shares will be repurchased in cash and at a price within the stock market price interval registered at any given time, such interval being the interval between the highest purchase price and the lowest sales price.
The repurchase of shares will be managed by an investment bank or financial institution and in accordance with the applicable rules and regulations in the Nordic Main Market Rulebook for Issuers of Shares.
For information on the implementation of the share repurchases, please see www.nasdaqomxnordic.com. Repurchase of shares will not be press released separately, unless mandatory disclosure obligations apply.
The total number of shares in the company amounts to 53,140,064, whereof 2,851 own shares are held by the company at the time of this press release.
For more information, please contact:
Noora Jayasekara, CFO, +46 70 318 92 97, noora.jayasekara@humana.se
Anna Sönne, Head of Investor Relations, +46 70 601 48 53, anna.sonne@humana.se